DAPK2 and polycystic ovary syndrome: In addition, DAPK2 exhibited good discriminatory capability in the diagnosis of HA PCOS versus controls (AUC = 0.806, 95% CI: 0.653-0.958) and versus NHA PCOS (AUC = 0.674, 95% CI: 0.408-0.940).